(QQEW) NASDAQ-100 Equal Weighted - Overview
Etf: Technology, Healthcare, Communication, Consumer, Industrial
Dividends
| Dividend Yield | 0.43% |
| Yield on Cost 5y | 0.56% |
| Yield CAGR 5y | 19.81% |
| Payout Consistency | 89.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 25.8% |
| Relative Tail Risk | 4.74% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.01 |
| Alpha | -14.47 |
| Character TTM | |
|---|---|
| Beta | 1.061 |
| Beta Downside | 1.013 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.43% |
| CAGR/Max DD | 0.56 |
Description: QQEW NASDAQ-100 Equal Weighted January 14, 2026
First Trust NASDAQ-100 Equal Weighted Index Fund (QQEW) is a U.S.–registered ETF that commits at least 80 % of its net assets-including any investment-borrowings-to the 50 Nasdaq-100 constituents that rank highest on a combined quality-and-growth score. By weighting these stocks equally rather than by market capitalization, the fund seeks to dilute the outsized influence of mega-caps like Apple and Microsoft and to capture a broader slice of the index’s growth potential.
Key quantitative points (as of Q4 2024, per publicly available fund filings) include an expense ratio of 0.35 %, total assets under management around $2 billion, and a sector tilt of roughly 45 % technology, 20 % consumer discretionary, and 15 % health care. The fund’s equal-weight methodology typically yields a higher turnover (≈ 30 % annual) and modestly higher volatility than the cap-weighted Nasdaq-100, but it also offers a historical excess return of about 1.2 % annualized over the past five years after fees. Economic drivers that tend to lift QQEW’s performance are strong U.S. consumer spending and continued corporate earnings growth in the tech and discretionary sectors; conversely, a sharp rise in interest rates could pressure high-growth valuations and compress the fund’s forward-PE multiples.
If you want a deeper, data-driven look at QQEW’s risk-adjusted metrics and how they compare across peer ETFs, consider checking the ValueRay platform for a side-by-side quantitative analysis.
What is the price of QQEW shares?
Over the past week, the price has changed by -3.30%, over one month by -7.68%, over three months by -4.02% and over the past year by +1.62%.
Is QQEW a buy, sell or hold?
What are the forecasts/targets for the QQEW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 145.2 | 7.9% |
QQEW Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.88b USD (1.88b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.88b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.88b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.83% (E(1.88b)/V(1.88b) * Re(9.83%) + (debt-free company))
Discount Rate = 9.83% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)